Navigation Links
COR in Medical News

Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results

... costs. "The recent completion of the cor Phase 3 program was a major milestone for ... co-primary endpoints. Key top-line data from the cor Phase 3 program include the following: ... Key secondary endpoints met in the cor Phase 3 program included significant improvements ...

Cantel Medical's Mar Cor Purification Subsidiary Acquires G.E.M. Water Systems ... Establishing a Nationwide Reach in Water Treatment

... MEDICAL CORP. (NYSE: CMN ), through its Mar cor Purification subsidiary, has continued the ... year. Curt Weitnauer, President of Mar cor Purification, stated, "Adding G.E.M.'s strong ... foundation for a West Coast expansion of the Mar cor service business." Cantel's President and ...

-Contrave(R) Obesity Research Phase 3 Program Meets Co-Primary and Key Secondary Endpoints; Exceeds FDA Efficacy Benchmark for Obesity Treatments-

... half of 2010. Key top-line data from the cor Phase 3 program include the following: ... Key secondary endpoints met across the entire cor Phase 3 program included significant improvements ... generally well tolerated by patients across the cor Phase 3 program. ...

Rcadia Medical Imaging Closes $3.3 Million Investment Led by BioVentures Investors

... -- Rcadia Medical Imaging, Ltd., developer of the cor Analyzer(TM) software for the automated analysis ... after a Coronary CTA study, the cor Analayzer(TM) identifies patients who need ... will fund the full commercial launch of the cor Analyzer(TM) and the establishment of a U.S. ...

Landmark Study Aims to Improve Osteoporosis Care Standards Worldwide

... as the population ages. About the Center for Outcomes Research (COR) cor is based at the University of Massachusetts, Worcester, MA, USA. The mission of cor is to collect and evaluate data that reflect real world practices and ...

Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer

... Mr. Kailian was the Chief Executive Officer, President, and a director of cor Therapeutics, Inc. He became the CEO of cor shortly after the company was founded, took the company public in 1991, ...

NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available for Relief of Moderate to Severe Acute Pain

... with conditions accompanied by hypoxia, hypercapnia or decreased respiratory reserve such as: asthma, chronic obstructive pulmonary disease or cor pulmonale, severe obesity, sleep apnea syndrome, myxedema, kyphoscoliosis, CNS depression, or coma. In such patients, even usual therapeutic doses ...

Xanodyne Announces Appointment of Mr. Vaughn M. Kailian of MPM Capital to the Board of Directors

... and the New England Healthcare Institute. Mr. Kailian has numerous accomplishments in the pharmaceutical industry including serving as CEO of cor Therapeutics, Inc. (1990-2002) where he took the company public in 1991, raised almost $1 billion in public market capital, and led the $2 billion ...

Conrad A. Conrad Elected Chairman of the Board for Rural/Metro Corporation

... joined the Rural/Metro Board of Directors in October 2005 and has served as a member of both the Audit and Compensation committees. He succeeds Mr. cor Clement, who announced earlier this year he would retire from the Board of Directors at the end of June. "I am honored to serve as Chairman of the ...
COR in Medical Technology

Rcadia's COR Analyzer Family of Products Receives Second FDA Clearance

... Drug Administration (FDA) clearance to market its cor Analyzer family of products, which assists in ... a high negative predictive value (NPV). Rcadia's cor Analyzer system uses proprietary image ... who do not have coronary artery disease. "The cor Analyzer is expected to assist the ED staff in ...

New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal

... with conditions accompanied by hypoxia, hypercapnia or decreased respiratory reserve such as: asthma, chronic obstructive pulmonary disease or cor pulmonale, severe obesity, sleep apnea syndrome, myxedema, kyphoscoliosis, CNS depression, or coma. In such patients, even usual therapeutic doses ...

FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain

... with conditions accompanied by hypoxia, hypercapnia or decreased respiratory reserve such as: asthma, chronic obstructive pulmonary disease or cor pulmonale, severe obesity, sleep apnea syndrome, myxedema, kyphoscoliosis, CNS depression, or coma. Patients receiving other mu-opioid agonist ...

International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis

... by prolonged bed rest, age over 60, or a previous history of VTE. About cor (Center for Outcomes Research) The Center for Outcomes Research (COR) ... data management and publication development. Established in 1994, cor is an outgrowth of the Worcester Deep Vein Thrombosis Study, a five-year ...
COR in Medical Definition

Pathology

... Angina pectoris - Prinzmetal's angina - Myocardial infarction - Dressler's syndrome Pulmonary circulation Pulmonary embolism - cor pulmonale Pericardium Pericarditis - Cardiac tamponade Endocardium / heart valves Endocarditis - Mitral regurgitation - ...
COR in Medical Dictionary

Cor pulmonale

... cor pulmonale is failure of the right side of the ... Continued Below Right -sided heart failure - cor pulmonale ... cor PULMONALE - Enlargement of the right ...

Congenital Heart Disease

... babies (8 per 1,000). This figure is an underestimate since it does not include some common problems, namely: ... congenital heart disease cor pulmonale pulmonary fibrosis Polycythemia vera Dehydration (such as from severe diarrhea ) Renal ( kidney ) disease with high ...
COR in Biological Technology

Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures

... About the Center for Outcomes Research (COR) cor is based at the University of Massachusetts, Worcester, MA, USA. The mission of cor is to collect and evaluate data that reflect real world practices and ...

The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis

... acute medical or surgical patients were eligible for the survey. About cor (Center for Outcomes Research) The Center for Outcomes Research (COR) ... data management and publication development. Established in 1994, cor is an outgrowth of the Worcester Deep Vein Thrombosis Study, a five-year ...

Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, as Chief Executive Officer

... technology. The firm's investments in life sciences include: ArthroCare, Aspreva Pharmaceuticals Corporation (acquired by Galenica group, SWX: GALN), cor Therapeutics (acquired by Millennium Pharmaceuticals), Corixa (acquired by GlaxoSmithKline, GSK), Coulter Pharmaceutical (acquired by Corixa ...

Physicians in Europe Rate Novartis #1 on Service Delivery, While Merck Earns Top Honors in the US

... relationships for each measured company, using TNS Healthcare's proprietary TRI*M(TM) Index. R ela t ionship S cor e s Fall e ven f or T o p C o mpanies Even for companies earning high ratings ...

Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors

... the appointment of Roger G. Stoll, Ph.D. to Delcath's Board of Directors. Dr. Stoll is Executive Chairman of Cortex Pharmaceuticals, Inc. (Amex: cor ), a biotechnology company specializing in the treatment of central nervous system disorders. (Logo: ...

MAP Pharmaceuticals Appoints Marco Rosa Vice President of Human Resources

... launch of several ophthalmology and surgical microscopy devices. Prior to Carl Zeiss, Mr. Rosa served as Vice President, Human Resources at cor Therapeutics, Inc., building the development and commercial organizations and launching Integrilin(R) in the cardiovascular angioplasty market. ...

Xenome Names Ian T. Nisbet, PhD as Chief Executive Officer

... at Millennium he was project leader for the US approval and launch of VELCADE(R) and was part of the team that managed the merger of Millennium and cor Therapeutics in 2001. During his period as CEO of Meditech, Ian led the negotiations with Alchemia that resulted in the first merger of two ...
Other Contents
(Date:10/22/2014)... King of Prussia, PA (PRWEB) October 22, 2014 ... Group, is recognized as an industry leader with over ... industry award winning team leader in the areas related ... In addition, Mr. Carlson is an Editorial Advisory Board ... Group Healthcare Council Educator. Blue Fin Group is ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter , ... in vitro fertilization (IVF) are only about half as likely ... reproduction technique, new research indicates, and the racial disparity persists ... about 31 percent of white patients became pregnant after IVF, ... more than 4,000 IVF cycles over two years to tease ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, 2014 ... fertilization (IVF) -- the incubation of embryos in a laboratory ... the vagina, new research suggests. Scientists from the United ... might sharply cut costs for pricey IVF procedures among certain ... those who don,t live near big-city assisted reproduction centers, the ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, 2014 (HealthDay News) -- ... NBC News in Liberia has cleared the virus from ... Medical Center in Omaha, where he had been treated for the ... confirmed by the U.S. Centers for Disease Control and Prevention found ... NBC News reported Tuesday night. "Recovering from Ebola is ...
(Date:10/20/2014)... Allegheny General Hospital’s (AGH) Cardiovascular Institute is offering ... a damaged mitral valve as the heart continues to ... Abbott Vascular , is designed to treat degenerative ... which the heart’s mitral valve leaflets fail to close ... left ventricle into the left atrium. The heart must ...
Breaking Medicine News(10 mins):Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3
(Date:10/17/2014)... German . Why ... order to reproduce? And why are there two sexes anyway? ... issue of the research journal Molecular Human Reproduction ... from Bielefeld University Bielefeld has compiled this special issue on ... female to copulate with several males in quick succession – ...
(Date:10/16/2014)... have a new synthesis of recent research findings to ... in the two states. , The Ecology and ... Washington: A Synthesis of the Relevant Biophysical Science and ... published by the U.S. Forest Service,s Pacific Northwest Research ... managers for a synthesis of the large body of ...
(Date:10/16/2014)... 2014 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market ... Wocket™, the Smart Wallet, at the 13 th ... leading global conference on the intersection of technology and ... Anderson , founder and publisher of the Strategic News ...
Breaking Biology News(10 mins):Sperm wars 2New report synthesizes best available science on management of moist mixed-conifer forests 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3
Other TagsOther Tags